FXYD3: A Promising Biomarker for Urothelial Carcinoma | Zendy

Zhongfa Zhang | Zendy; SeeTong Pang | Zendy; Katherine A. Kasper | Zendy; Chunyan Luan | Zendy; Bill Wondergem | Zendy; Fan Lin | Zendy; ChengKeng Chuang | Zendy; Bin Tean Teh | Zendy; Ximing J. Yang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

FXYD3: A Promising Biomarker for Urothelial Carcinoma

Author(s) -

Zhongfa Zhang,

SeeTong Pang,

Katherine A. Kasper,

Chunyan Luan,

Bill Wondergem,

Fan Lin,

ChengKeng Chuang,

Bin Tean Teh,

Ximing J. Yang

Publication year - 2011

Publication title -

biomarker insights

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.075

H-Index - 31

ISSN - 1177-2719

DOI - 10.4137/bmi.s6487

Subject(s) - kidney cancer , kidney , medicine , chromophobe cell , immunohistochemistry , pathology , biomarker , tissue microarray , renal cell carcinoma , differential diagnosis , oncocytoma , carcinoma , clear cell , biology , biochemistry

Urothelial carcinoma (UC) of the kidney is a relatively rare but aggressive form of kidney cancer. Differential diagnosis of renal UC from renal cell carcinoma (RCC) can be difficult, but is critical for correct patient management. We aimed to use global gene expression profiling to identify genes specifically expressed in urothelial carcinoma (UC) of the kidney, with purpose of finding new biomarkers for differential diagnosis of UC of both upper and lower tract from normal tissues.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research